Jounce Therapeutics, Inc. Stock price
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 17 M€ | +5.93% | - |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.61% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.31% | 16.19B | |
+4.68% | 13.72B | |
+34.15% | 12.22B |